Adverse effects of molgramostim in marrow transplant recipients

Clin Pharm. 1993 Jul;12(7):520-5.

Authors

C Ippoliti¹, D Przepiorka, T Smith, S Maiese, S Giralt, B S Andersson, A B Deisseroth, R E Champlin

Affiliation

¹ University of Texas M.D. Anderson Cancer Center, Division of Pharmacy, Houston 77030.

PMID: 8354039

No abstract available

MeSH terms

Adolescent
Adult
Bone Marrow Transplantation* / adverse effects
Bone Marrow Transplantation* / methods
Female
Granulocyte-Macrophage Colony-Stimulating Factor / administration & dosage
Granulocyte-Macrophage Colony-Stimulating Factor / adverse effects*
Humans
Injections, Subcutaneous
Male
Middle Aged
Recombinant Proteins / administration & dosage
Recombinant Proteins / adverse effects
Retrospective Studies
Risk Factors

Substances

Recombinant Proteins
Granulocyte-Macrophage Colony-Stimulating Factor
molgramostim